Jingjing Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jingjing Song has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Jiansong Ji
Department of Radiology, Lishui Hospital of Zhejiang University, Lishui, China
5 shared publications - Jianfei Tu
Ningbo University
3 shared publications - Minjiang Chen
Department of Pulmonary and Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
3 shared publications - Zhongwei Zhao
Medical College, Yanbian University, Yanji, People’s Republic of China
3 shared publications Chenying Lu
Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical University, Affiliated Lishui Hospital of Zhejiang University, The Central Hospital of Zhejiang Lishui, Lishui, 323000, China; Department of Radiology, The Fifth Affiliated Hospital of Wenzhou Medical University, Affiliated Lishui Hospital of Zhejiang University, The Central Hospital of Zhejiang Lishui, Lishui, 323000, China
2 shared publicationsFazong Wu
Department of radiology, Lishui Hospital of Zhejiang University, School of Medicine, Lishui 323000, China
2 shared publications
Latest Publications
- 4 January 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 231, 123160
Monodisperse CaCO3-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatment
- 4 January 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 231, 123160
Monodisperse CaCO3-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatment
- 1 February 2020
- Published by Elsevier in Cancer Letters
- Vol. 470, 84-94
Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases
- 1 February 2020
- Published by Elsevier in Cancer Letters
- Vol. 470, 84-94
Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases
- 1 September 2019
- Published by Elsevier in Cancer Letters
- Vol. 460, 119-127
Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT
- 1 September 2019
- Published by Elsevier in Cancer Letters
- Vol. 460, 119-127
Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT
- 17 June 2019
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 147 (1) , 29-35
Short‐term efficacy, safety, and cost‐effectiveness of transarterial chemoembolization with drug‐eluting beads versus synchronous radiochemotherapy for cervical cancer
Objective: To investigate the short‐term efficacy and safety of transarterial chemoembolization with drug‐eluting beads (DEB‐TACE) versus synchronous radiochemotherapy among women with cervical cancer.Methods: A retrospective cohort study of women treated by synchronous radiochemotherapy (n=20) and DEB‐TACE (n=20) at a single center in China between November 2015 and September 2017. Inclusion criteria were pathologic diagnosis of cervical cancer, age at least 18 years, and complete clinicopathologic information. Hospital stay, direct medical cost, resection frequency, adverse events, treatment responses, progression‐free survival (PFS) and overall survival (OS) were compared between treatments.Results: There was no difference in treatment responses, PFS, or OS between the two groups. Hospital stay was shorter, direct medical costs were lower, and resection rate was higher in the DEB‐TACE group than in the radiochemotherapy group (all P<0.05). In univariate and multivariate logistic regression analysis, no factor was associated with complete response. No predictive factor for PFS or OS was identified by Cox proportional regression analysis. Fewer adverse advents were recorded in the DEB‐TACE group than in the synchronous radiochemotherapy group.Conclusion: Among women with cervical cancer, DEB‐TACE achieved equal short‐term efficacy, better tolerance, less hospital stay and medical costs, and higher resection rates as compared with synchronous radiochemotherapy.
- 17 June 2019
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 147 (1) , 29-35
Short‐term efficacy, safety, and cost‐effectiveness of transarterial chemoembolization with drug‐eluting beads versus synchronous radiochemotherapy for cervical cancer
Objective: To investigate the short‐term efficacy and safety of transarterial chemoembolization with drug‐eluting beads (DEB‐TACE) versus synchronous radiochemotherapy among women with cervical cancer.Methods: A retrospective cohort study of women treated by synchronous radiochemotherapy (n=20) and DEB‐TACE (n=20) at a single center in China between November 2015 and September 2017. Inclusion criteria were pathologic diagnosis of cervical cancer, age at least 18 years, and complete clinicopathologic information. Hospital stay, direct medical cost, resection frequency, adverse events, treatment responses, progression‐free survival (PFS) and overall survival (OS) were compared between treatments.Results: There was no difference in treatment responses, PFS, or OS between the two groups. Hospital stay was shorter, direct medical costs were lower, and resection rate was higher in the DEB‐TACE group than in the radiochemotherapy group (all P<0.05). In univariate and multivariate logistic regression analysis, no factor was associated with complete response. No predictive factor for PFS or OS was identified by Cox proportional regression analysis. Fewer adverse advents were recorded in the DEB‐TACE group than in the synchronous radiochemotherapy group.Conclusion: Among women with cervical cancer, DEB‐TACE achieved equal short‐term efficacy, better tolerance, less hospital stay and medical costs, and higher resection rates as compared with synchronous radiochemotherapy.
- 1 August 2018
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 288 (2) , 612-620
Non–Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia–enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy
Radiofrequency hyperthermia-enhanced gene therapy may introduce a paradigm for effective management of unresectable lung cancer by integrating the advantages of interventional molecular imaging with direct intratumoral gene therapy. Purpose To validate the feasibility and efficacy of intratumoral radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus (HSV) thymidine kinase (TK) and ganciclovir (GCV) (hereafter, HSV-TK/GCV) gene therapy for non–small-cell lung cancer (NSCLC). Materials and Methods This study was performed from November 11, 2015, to April 14, 2017, and included (a) in vitro experiments with human NSCLC cells to establish the proof of principle, (b) in vivo experiments using mice with subcutaneous NSCLC to further demonstrate the principle, and (c) in vivo experiments using rats with orthotopic NSCLC to validate the technical feasibility. Cells, nude mice, and nude rats were randomly divided into four groups (six animals per group): (a) combination therapy (HSV-TK/GCV combined with RFH), (b) RFH, (c) HSV-TK/GCV, and (d) phosphate-buffered saline. Data were analyzed by using the Dunnett t test or Kruskal–Wallis test. Results For in vitro experiments, the cell proliferation assay showed significantly diminished v...
- 1 August 2018
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 288 (2) , 612-620
Non–Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia–enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy
Radiofrequency hyperthermia-enhanced gene therapy may introduce a paradigm for effective management of unresectable lung cancer by integrating the advantages of interventional molecular imaging with direct intratumoral gene therapy. Purpose To validate the feasibility and efficacy of intratumoral radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus (HSV) thymidine kinase (TK) and ganciclovir (GCV) (hereafter, HSV-TK/GCV) gene therapy for non–small-cell lung cancer (NSCLC). Materials and Methods This study was performed from November 11, 2015, to April 14, 2017, and included (a) in vitro experiments with human NSCLC cells to establish the proof of principle, (b) in vivo experiments using mice with subcutaneous NSCLC to further demonstrate the principle, and (c) in vivo experiments using rats with orthotopic NSCLC to validate the technical feasibility. Cells, nude mice, and nude rats were randomly divided into four groups (six animals per group): (a) combination therapy (HSV-TK/GCV combined with RFH), (b) RFH, (c) HSV-TK/GCV, and (d) phosphate-buffered saline. Data were analyzed by using the Dunnett t test or Kruskal–Wallis test. Results For in vitro experiments, the cell proliferation assay showed significantly diminished v...
- Open Access
- 28 March 2018
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 9, 420
Do Future Limitation Perspective in Cancer Patients Predict Fear of Cancer Recurrence, Mental Distress, and the Ventromedial Prefrontal Cortex Activity?
Life-threatening diseases (e.g., cancer) affect people’s future time perspective (FTP) and affect their mental health. When one’s lifetime is perceived as running out, the individual possesses a future limitation perspective (FLP), which is one of factors in FTP. In this study, we explored the structural relationship between FLP, fear of cancer recurrence (FCR), mental health status (MHS), and brain activity in patients with cancer. Cancer patients were divided into two groups using the FTP scale and Feelings About Life Scale: a strong FLP group (S-FLP) and a weak FLP group (W-FLP). For these groups, we measured cancer patients’ MHS using the Symptom Checklist (SCL-90) and FCR using the Cancer Acceptance Scale; brain activity was measured using resting-state functional magnetic resonance imaging (rs-fMRI). Behavioral results showed that the S-FLP group had higher mental symptoms and FCR scores than did the W-FLP group. Neuroimaging results revealed that spontaneous brain activity in the ventromedial prefrontal cortex (vmPFC) was stronger in the W-FLP group than in the S-FLP group. Moreover, brain activity in the vmPFC negatively correlated with FLP, FCR, and SCL-90 scores only in the S-FLP group, and the model constructed further indicated that FCR and SCL-90 scores fully mediated the relationship between FLP and vmPFC activities. These findings suggested that a strong FLP might lead to mental disorders and greater FCR, which might change the spontaneous activity of the vmPFC in cancer patients.
- 28 March 2018
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 9, 420
Open AccessDo Future Limitation Perspective in Cancer Patients Predict Fear of Cancer Recurrence, Mental Distress, and the Ventromedial Prefrontal Cortex Activity?
Life-threatening diseases (e.g., cancer) affect people’s future time perspective (FTP) and affect their mental health. When one’s lifetime is perceived as running out, the individual possesses a future limitation perspective (FLP), which is one of factors in FTP. In this study, we explored the structural relationship between FLP, fear of cancer recurrence (FCR), mental health status (MHS), and brain activity in patients with cancer. Cancer patients were divided into two groups using the FTP scale and Feelings About Life Scale: a strong FLP group (S-FLP) and a weak FLP group (W-FLP). For these groups, we measured cancer patients’ MHS using the Symptom Checklist (SCL-90) and FCR using the Cancer Acceptance Scale; brain activity was measured using resting-state functional magnetic resonance imaging (rs-fMRI). Behavioral results showed that the S-FLP group had higher mental symptoms and FCR scores than did the W-FLP group. Neuroimaging results revealed that spontaneous brain activity in the ventromedial prefrontal cortex (vmPFC) was stronger in the W-FLP group than in the S-FLP group. Moreover, brain activity in the vmPFC negatively correlated with FLP, FCR, and SCL-90 scores only in the S-FLP group, and the model constructed further indicated that FCR and SCL-90 scores fully mediated the relationship between FLP and vmPFC activities. These findings suggested that a strong FLP might lead to mental disorders and greater FCR, which might change the spontaneous activity of the vmPFC in cancer patients.
- Open Access
- 14 March 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (16) , 22186-22192
SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han population
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Jiansong Ji1, *, Min Xu1, *, Zhongwei Zhao1, *, Jianfei Tu1, *, Jun Gao2, *, Chenying Lu1, Jingjing Song1, Weiqian Chen1, Minjiang Chen1, Xiaoxi Fan1, Xingyao Cheng1, Xilin Lan1, Jie Li3 1Department of Radiology, The Fifth Affiliated Hospital of Wenzhou Medical University/Affiliated Lishui Hospital of Zhejiang University/The Central Hospital of Zhejiang Lishui, Lishui, Zhejiang, P.R. China 2Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing, P.R. China 3The First Affiliated Hospital, Chongqing Medical University, Chongqing, P.R. China *These authors contributed equally to this work Correspondence to: Jiansong Ji, e-mail: jijiansongzjls@163.com Keywords: HCC, mothers against decapentaplegic homolog 7 (SMAD7), transforming growth factor beta (TGF-β), risk, SNP Received: November 05, 2015 Accepted: February 05, 2016 Published: March 14, 2016 ABSTRACT Genome-wide association studies (GWAS) have identified three loci at 18q21 (rs4939827, rs7240004, and rs7229639), which maps to SMAD7 loci, were associated with risk of diseases of the digestive system. However, their associations with hepatocellular carcinoma (HCC) risk remain unknown. A case-control study was conducted to assess genetic associations with HCC risk and clinicopathologic development among Chinese Han population. Three SNPs were genotyped among 1,000 HCC cases and 1,000 controls using Sequenom Mass-ARRAY technology. We observed statistically significant associations for the three SMAD7 loci and HCC risk. Each copy of minor allele was associated with a 1.24–1.36 fold increased risk of HCC. We also found that significant differences were observed between rs4939827 and clinical TNM stage and vascular invasion, as well as rs7240004 and vascular invasion. We also established a genetic risk score (GRS) by summing the risk alleles. The GRS was significantly associated with increased risk of HCC and vascular invasion. Our data revealed the SMAD7 loci is associated with HCC susceptibility and its clinicopathologic development.
- 14 March 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (16) , 22186-22192
Open AccessSMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han population
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Jiansong Ji1, *, Min Xu1, *, Zhongwei Zhao1, *, Jianfei Tu1, *, Jun Gao2, *, Chenying Lu1, Jingjing Song1, Weiqian Chen1, Minjiang Chen1, Xiaoxi Fan1, Xingyao Cheng1, Xilin Lan1, Jie Li3 1Department of Radiology, The Fifth Affiliated Hospital of Wenzhou Medical University/Affiliated Lishui Hospital of Zhejiang University/The Central Hospital of Zhejiang Lishui, Lishui, Zhejiang, P.R. China 2Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing, P.R. China 3The First Affiliated Hospital, Chongqing Medical University, Chongqing, P.R. China *These authors contributed equally to this work Correspondence to: Jiansong Ji, e-mail: jijiansongzjls@163.com Keywords: HCC, mothers against decapentaplegic homolog 7 (SMAD7), transforming growth factor beta (TGF-β), risk, SNP Received: November 05, 2015 Accepted: February 05, 2016 Published: March 14, 2016 ABSTRACT Genome-wide association studies (GWAS) have identified three loci at 18q21 (rs4939827, rs7240004, and rs7229639), which maps to SMAD7 loci, were associated with risk of diseases of the digestive system. However, their associations with hepatocellular carcinoma (HCC) risk remain unknown. A case-control study was conducted to assess genetic associations with HCC risk and clinicopathologic development among Chinese Han population. Three SNPs were genotyped among 1,000 HCC cases and 1,000 controls using Sequenom Mass-ARRAY technology. We observed statistically significant associations for the three SMAD7 loci and HCC risk. Each copy of minor allele was associated with a 1.24–1.36 fold increased risk of HCC. We also found that significant differences were observed between rs4939827 and clinical TNM stage and vascular invasion, as well as rs7240004 and vascular invasion. We also established a genetic risk score (GRS) by summing the risk alleles. The GRS was significantly associated with increased risk of HCC and vascular invasion. Our data revealed the SMAD7 loci is associated with HCC susceptibility and its clinicopathologic development.